A Double-Blind Controlled Trial of Long Chain N-3 Polyunsaturated Fatty Acids in the Treatment of Multiple Sclerosis.

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp.52.1.18